SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

77,033.53 76.26
( 0.10%)

Global Indices

Nasdaq

53,227.35 -353.64
(-0.66%)

Dow Jones

7,711.10 -21.66
(-0.28%)

Hang Seng

66,147.06 -258.50
(-0.39%)

Nikkei 225

10,824.26 31.76
(0.29%)

Forex

USD-INR

95.47 -0.01
(-0.01%)

EUR-INR

110.57 -0.67
(-0.60%)

GBP-INR

129.19 -0.55
(-0.42%)

JPY-INR

0.60 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

FDC Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

531599

INE258B01022

153.1011438

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

FDC

17.61

5476.12

EPS(TTM)

Face Value()

Div & Yield %

19.1

1.49

Back

KSB consolidated net profit declines 22.87% in the March 2026 quarter

Apr 30,2026

Net profit of KSB declined 22.87% to Rs 39.80 crore in the quarter ended March 2026 as against Rs 51.60 crore during the previous quarter ended March 2025. Sales rose 0.99% to Rs 601.30 crore in the quarter ended March 2026 as against Rs 595.40 crore during the previous quarter ended March 2025.

Particulars	Quarter Ended
	Mar. 2026	Mar. 2025	% Var.
Sales	601.30	595.40	1
OPM %	8.45	11.37	-
PBDT	67.80	82.90	-18
PBT	53.30	69.00	-23
NP	39.80	51.60	-23

77,033.53 76.26 ( 0.10%)

53,227.35 -353.64 (-0.66%)

7,711.10 -21.66 (-0.28%)

66,147.06 -258.50 (-0.39%)

10,824.26 31.76 (0.29%)

95.47 -0.01 (-0.01%)

110.57 -0.67 (-0.60%)

129.19 -0.55 (-0.42%)

0.60 0.00 (-0.48%)